中性粒细胞与淋巴细胞比值、放疗分割方式与技术及局部晚期直肠癌远处转移风险的关联
研究纳入2006至2019年接受新辅助放疗并同步或序贯化疗的1386例局部晚期直肠癌患者,评估中性粒细胞与淋巴细胞比值(NLR)的预后影响及放疗可调因素是否影响NLR。中位随访61.3个月,5年无远处转移生存率为80.1%;放疗后NLR≥4独立关联更差的无远处转移生存(HR 1.42,95%CI 1.12-1.80)。放疗后NLR升高与长程放疗及螺旋断层放疗更常见相关。
要点
- 放疗后NLR≥4独立关联更差的无远处转移生存,HR 1.42(95%CI 1.12-1.80)。
- 长程放疗较短程放疗更常出现放疗后NLR≥4升高,OR 2.77(p=0.012)。
- 螺旋断层放疗较三维适形放疗更常出现放疗后NLR≥4升高,OR 1.29(p<0.001)。
核心结论
- 新辅助放疗后NLR升高与局部晚期直肠癌患者远处转移风险增加及不良生存结局相关。
- 放疗后高NLR与放疗分割方式、照射技术和肿瘤特征直接相关。
- 上述结果仅用于提出假设,需要验证性研究。
研究设计与样本
- 评估2006至2019年间接受新辅助放疗并同步或序贯化疗的1386例局部晚期直肠癌患者的数据。
- 多数患者(97.8%)接受长程放疗(50-50.4 Gy,25-28次),采用三维适形放疗(n=851)或螺旋断层放疗(n=504);30例接受短程放疗(25 Gy,5次,随后卡培他滨联合奥沙利铂方案给药6周)。
- 在初诊时、术前放疗前及放疗期间、术前同步放化疗后获取中性粒细胞和淋巴细胞绝对计数;主要终点为无远处转移生存。
主要发现
- 中位随访时间61.3个月(范围4.1-173.7个月),5年无远处转移生存率为80.1%。
- 放疗后NLR≥4独立关联更差的无远处转移生存(HR 1.42,95%CI 1.12-1.80),更高的ypT和ypN分期亦独立相关。
- 放疗后NLR≥4升高在长程放疗后较短程放疗后更常见(OR 2.77,p=0.012),在螺旋断层放疗后较三维适形放疗后更常见(OR 1.29,p<0.001)。
关键数值与推荐
- 放疗后NLR≥4为独立预后因素,HR 1.42(95%CI 1.12-1.80)。
- 长程放疗与放疗后NLR≥4升高的OR为2.77(p=0.012)。
- 螺旋断层放疗与放疗后NLR≥4升高的OR为1.29(p<0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文结论指出这些结果仅用于提出假设,需要验证性研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We investigated the prognostic impact of the neutrophil-to-lymphocyte ratio (NLR) in patients with locally advanced rectal cancer (LARC) and whether modifiable factors in radiotherapy (RT) influenced the NLR. METHODS: Data of 1386 patients who were treated with neoadjuvant RT and concurrent or sequential chemotherapy for LARC between 2006 and 2019 were evaluated. Most patients (97.8%) were treated with long-course RT (LCRT; 50-50.4 Gy in 25-28 fractions) using three-dimensional conformal radiotherapy (3D-CRT) (n = 851) or helical tomotherapy (n = 504), and 30 patients underwent short-course RT (SCRT; 25 Gy in 5 fractions, followed by XELOX administration for 6 weeks). Absolute neutrophil and lymphocyte counts were obtained at initial diagnosis, before and during the preoperative RT course, and after preoperative concurrent chemoradiotherapy. The primary endpoint was distant metastasis-free survival (DMFS). RESULTS: The median follow-up time was 61.3 (4.1-173.7) months; the 5-year DMFS was 80.1% and was significantly associated with the NLR after RT but not before. A post-RT NLR ≥ 4 independently correlated with worse DMFS (hazard ratio, 1.42; 95% confidence interval, 1.12-1.80), along with higher ypT and ypN stages. Post-RT NLR (≥ 4) more frequently increased following LCRT (vs. SCRT, odds ratio [OR] 2.77, p = 0.012) or helical tomotherapy (vs. 3D-CRT, OR 1.29, p < 0.001). CONCLUSIONS: Increased NLR after neoadjuvant RT is associated with increased distant metastasis risk and poor survival outcome in patients with LARC. Moreover, high NLR following RT is directly related to RT fractionation, delivery modality, and tumor characteristics. These results are hypothesis-generating only, and confirmatory studies are required.
引用
- Yang G, Chang JS, Choi JE, et al. Association of neutrophil-to-lymphocyte ratio, radiotherapy fractionation/technique, and risk of development of distant metastasis among patients with locally advanced rectal cancer. Radiat Oncol. 2022. PMID: 35597954. doi:10.1186/s13014-022-02065-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。